This study is of translational relevance because Cyld transgenic mice fail to recapitulate the human CCS tumor phenotype,1 making the study of in vivo effects of TRK inhibition in humans with a topical intervention a necessary approach that overcomes this limitation. Here, CYLD is linked to neoplasm.